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ABSTRACT 
Outbreaks of Marek’s disease (MD) in vaccinated flocks still occur sporadically and lead to economic 
losses. This study reports the detection of serotypes 1 and 3 Marek’s disease virus using molecular 
techniques in pullets showing clinical signs of the disease. An enzyme-linked immunosorbent assay 
(ELISA) was applied to evaluate the antibody response of chicks and the diseased pullets from the 
same parent stock against Marek’s disease (MD) at 4 and 21weeks of age respectively. Despite vac-
cination at day old, antibody titre in the chicks was negative while it was highly variable in the diseased 
pullets. From the results, the susceptibility of previously vaccinated birds to the pathogenic strain of 
MDV indicates inappropriate vaccination at day old and a call for concern in the poultry industry. It is 
therefore recommended that serology be carried out on birds to determine their immune status before 
and after MD vaccination. 
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INTRODUCTION 
Marek’s disease (MD) is a highly contagious 
lympho-proliferative disease of chickens. 
The causative virus is cell associated and 
belongs to the subfamily Alphaherpesviri-
nae, family Herpesviridae (Witter and Schat, 
2003, Osterrieder and Vautherot, 2004). 
MD viruses have been subdivided into three 
serotypes: oncogenic strains and their atten-
uated variants are the members of serotype 
1; nonpathogenic strains from chickens are 
serotype 2; and nonpathogenic herpesvirus 
of turkey origin belongs to serotype 3. De-
spite the production of commercial vaccines 
from all three serotypes of the virus (Witter 
and Schat, 2003), there has been report of 
the outbreak of MD, which has been said to 
be able to cause a loss of approximately $1 
billion (Spencer et al., 1976; Okada et al., 
1977; Vallejo et al., 1998; Yonash et al., 
1999) in any outbreak per year, even in vac-
cinated flocks. Recent evidence has shown 
that the inability of existing live vaccines to 
prevent replication is the major factor for 
driving the virulence of the virus (Peter, 
2012). 
 
MATERIALS AND METHODS 
Case history 
A flock of 1015 twenty one (21) weeks old 
Bovans nera layer birds were reported to be 
anorexic and dull with mortality ranging be-
tween 2 and 4 daily. The daily egg produc-
tion of the flock had also stopped increasing 
and remained stagnant between 25 and 30%. 
Vaccines which had been administered to 
the birds included Newcastle disease (HB-1) 
and Marek’s disease (HVT) vaccines at day 
old, Infectious bursal disease vaccine at 15 
and 21 days of age, fowl pox vaccine at six 
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weeks old and a combination of Newcastle 
disease (Komarov strain) and egg drop syn-
drome vaccine at eighteen weeks of age. 
 
Clinical and necropsy examination 
Clinical observation in sick birds during the 
study was noted. A macroscopic post mor-
tem examination was conducted on the 
dead birds during the study period. The ab-
normality or lesion observed on a number 
of body organs and/or tissues was noted. 
 
Sample collection 
Tissue sample collection 
Tissue samples for detection of MDV were 
collected from the liver during post-mortem 
examination of dead birds. These were 
stored at -200C until they were screened 
using the polymerase chain reaction. 
 
Blood sample collection 
A total of 24 blood samples were collected 
randomly from birds from the affected 
flock while 20 blood samples were collected 
from 4weeks old birds from the same par-
ent stock on the same breeder farm. Blood 
was collected through the jugular vein into 
sterile bijou bottles and was allowed to clot 
on the bench for 1 hour at room tempera-
ture after which haemoglobin free sera were 
formed. These sera were transferred into 
1.5mL eppendorf tubes and stored at –200C 
until used. 
 
Detection of MDV antibody 
The MDV antibody in the serum samples 
were detected using the ELISA method as 
described by Adeniran and Oyejide (1995).  
Briefly, fifty microlitres (containing 50 dos-
es) of reconstituted MDV antigen in coating 
buffer was dispensed into each well of the 
microtitre plate. The plates were then incu-
bated at room temperature for 1h with oc-
casional agitation and thereafter incubated 
for 24h at 4°C. Plates were then flipped 
empty and wells washed three times (5min 
soaking) with the washing buffer. After 
which the plates were stamped on a dry pa-
per towel to make sure all the wells were 
properly dried.  
 
Dilutions of the positive, negative and test 
sera were made in sterile U-bottom microti-
tre plates using the dilution buffer and 50µL 
of each sera dilution was added into the wells 
in duplicate. After 1hour of incubation, the 
plates were flipped empty washed thrice 
(5min soaking) and stamped dry on paper 
towel. The Horse Radish Peroxidase (HRP) 
conjugate was added at 50µL per well, al-
lowed to incubate for 20min at room tem-
perature and the wash cycle was repeated 
3times (5min soaking) and dried. Chro-
mogen/substrate (50 µL per well) was then 
added at room temperature for color devel-
opment. Finally, the reaction was stopped 
with 50 µL of 0.1M H2SO4 after 10minutes. 
The optical density (OD) was measured at 
492nm wavelength using a Sunrise® (Touch 
screen model) ELISA plate reader. 
 
The following interpretations were made for 
optical density results: 
 
Upper limit of negativity (ULN) was taken as 
the mean OD value of negative control sera 
(0.833nm). Any serum with OD value great-
er than ULN (0.833nm) is regarded as con-
taining antibody. The higher the OD value, 
the higher the quantity (level) of antibody. 
Optical density readings ranged from nega-
tive (0.400-0.800 nm), strong (0.835-1.000 
nm) to very strong (1.000-1.116 nm). 
 
Detection of MDV DNA 
Procedure for DNA Isolation and Purifi-
cation 
Isolation of MDV DNA from samples and 
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its purification was done using Qiagen RNA 
minikit (QIAGEN GmbH, Germany), fol-
lowing the manufacturers procedure. 
 
The polymerase chain reaction for MDV 
was carried out by adding 2.5μl of DNA to 
22.5μl of PCR mix containing 17.2μl of dis-
tilled water, 2.5μl of 10X PCR buffer, 2.0μl 
of MgCl2 (50mM), 0.5μl of dNTP (10mM), 
0.1μl of forward and reverse primer for all 
MDV serotypes or primers specific for the 
3 serotypes of MDV and 0.1μl of taq poly-
merase (5μ/μl).  
 
Polymerase Chain Reaction (PCR) 
The PCR reactions was carried out using 
the following cycling conditions; initial de-
naturation at 940C for 5min, 35 cycles of 
amplification at 940C for 30 sec, 550C for 30 
sec and 720C for 1min and final extension 
at 720C for 10min. The PCR product sizes 
were visualized by UV illumination in 2% 
agarose gel stained with ethidium bromide 
as compared to the 1kb+ size (invitrogen). 
The positive specimens were detected with 
band at 491bp for all MD serotypes, 446bp 
for serotype 1, 327bp for serotype 2 and 
316bp for serotype 3.   
 
RESULT 
Post mortem examination 
Post-mortem examination carried out 
showed the liver was grossly enlarged with 
presence of focal nodules. Miliary nodules 
were also present throughout the entire 
length of the intestine, surface of the lungs 
and on the heart and kidney surfaces. Sciatic 
nerve was not seen to be enlarged.  
 
Marek’s disease Virus detection 
Tissue samples collected for Marek’s disease 
virus detection in the laboratory were posi-
tive for the virus. This samples were positive 
for MDV (491bp) generally, MDV1 (446bp) 
and MDV3 (316bp) as shown in Figure 1. 
65 
M   1   2  3   4   5   6  7   8   9  10  11 12 M 
100bp 
500bp 
Figure 1: Agarose electrophoresis for the detection of genome segment of serotypes 1, 2 and 3 of 
Marek’s disease virus. PCR products were separated on ethidium bromide stained 2% agarose gel. 
Wells 1, 2, 3 contains MDV PCR product (491bp), wells 4, 5, 6, contains MDV 1 PCR product (446bp), 
wells 7, 8, 9 contains MDV 2 (327bp) PCR product and wells 10, 11, 12 contains MDV 3 PCR product 
(316bp). 
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Marek’s disease antibody detection 
The chickens for this study had been previ-
ously vaccinated with HVT vaccine at day 
old in the hatchery. Result from the twenty 
four chickens tested from the affected flock 
showed the level of antibody in sera from 
the birds ranged from being negative to 
very strong (figure 2). The result from 
4weeks old birds on the same farm from the 
same parent stock with the adult birds 
showed the level of antibody to be zero 
(figure 3). This is despite the HVT vaccine 
that had been administered at day old in the 
hatchery. 
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Figure 2: Chart showing MD antibody titre of individual 24 weeks old bird and  
 negative control Samples 1 to 24 are field samples and 25 is negative control 
            OD= Optical density 
Figure 2: Chart showing MD antibody titre of individual 24 weeks old bird and  
 negative control Samples 1 to 24 are field samples and 25 is negative control 
 OD= Optical density 
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DISCUSSION 
Molecular techniques have been used for 
the detection of Marek’s disease in some 
poultry flocks in Nigeria (Owoade and Oni, 
2008), were a 491bp amplicon common for 
all the serotypes of MDV and specific to 
the highly conserved region of the gB MDV 
gene was amplified. In this study however, 
aside amplifying the gB MDV gene, three 
pairs of internal primers were used to syn-
thesize serotype-specific PCR amplicon, (gB 
MDV-1 F and gB MDV-1 R, gB MDV-2 F 
and gB MDV-2 R, gB MDV-3 F and gB 
MDV-3 R), which are specific to the hyper-
variable region of gB MDV gene (Owoade 
and Oni, 2008). 
 
Results from this study indicate the pres-
ence of serotypes 1 and 3 of Marek’s disease 
virus in the sampled flocks. These serotypes 
are the pathogenic Marek’s disease virus 
and the Herpes virus of turkey respectively. 
The presence of the pathogenic strain is 
witnessed with the rate of morbidity and 
mortality on the farm. The birds were nega-
tive for the serotype 2 (apathogenic strain) of 
Marek’s disease virus. 
 
Some studies have showed that there could 
be great variability of incidence of MD in 
houses on the same site and even between 
pens within a house and that this was related 
to factors occurring during the first 8 weeks 
of life (Davison, 2004). It was discovered 
that viruses of variable pathogenicity were 
present, ranging from apathogenic, through 
mildly pathogenic to the very pathogenic in 
each group of chickens (Davison, 2004). 
This may be responsible for the birds in the 
other pen house not infected despite being 
on the same location. 
 
It was also found that the use of HVT vac-
cine alone for vaccination at day old did not 
provide good protection against these strains 
but a better immunity was conferred when 
Figure 3: Chart showing MD antibody titre of individual 4 weeks old bird and  
     negative control Samples 1 to 22 are field samples and sample 23 is  
     negative control OD= Optical density 
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HVT was combined with CVI988/Rispens 
vaccine (Schat and Nair, 2008). The birds 
on this farm were vaccinated with HVT at 
day 1 which would be the reason why the 
birds became infected. 
 
Studies have also showed that vaccination 
with HVT at 1 day of age become more 
effective with increasing time between vac-
cination and challenge (Peter and Venu-
gopal, 2012). Since the birds were vaccinat-
ed at day 1 and were 24weeks old at the 
time of infection, it indicated that some fac-
tors like poor nutrition and secondary bac-
terial or viral infection might have sup-
pressed the immunity of the birds or that 
the vaccine was not potent when it was ad-
ministered. 
 
Despite the widespread use of vaccines, 
MD outbreaks still occur in different coun-
tries (Baigent et al. 2006). Factors such as 
improper storage or administration of Ma-
rek’s disease vaccine, presence of maternal 
antibodies in the chicks, suppression of im-
mune system by other pathogens or stress, 
and emergence of vv or vv+ MDV in the 
field have been said to be responsible for 
many outbreaks of MD (Baigent et al. 
2006). In this case, the factor responsible 
for this outbreak would not be ascertain but 
it’s most likely due to administration of a 
poor vaccine to the birds at day 1 as the 
other 4week old birds were antibody nega-
tive. It is therefore recommended that serol-
ogy be carried out on birds to determine 
their immune status before and after MD 
vaccination. 
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